Gene Query: AREG

Dataset Description Geneva Score
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 250.82
Differential analysis of gene regulation at transcript resolution by RNA-Seq 250.82
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 219.16
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 219.16
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 208.84
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 187.58
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 178.96
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 141.02
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 118.96
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 112.46
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 102.4
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 101.23
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 99.69
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 98.62
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 97.25
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 87.06
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 86.08
G-quadruplex structures mark human regulatory chromatin 84.77
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 83.02
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 81.79
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 81.79
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 81.76
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 81.76
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 81.7
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 80.46
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 77.8
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 77.8
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 75.31
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 72.38
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 72.38
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 72.37
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 72.37
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 68.51
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 68.14
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 68.12
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 68.12
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 67.03
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 66.61
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 64.69
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 64.4
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 64.13
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 64.13
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 63.28
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 61.83
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 61.29
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 60.67
Transcriptomic profiling of human peripheral blood-derived mast cells 58.82
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 58.82
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 58.71
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 58.27
Genome wide expression change in LCC2 and MCF-7 cells 56.06
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 55.49
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 55.08
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 55.08
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 54.83
BAF controls genome accessibility 54.73
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 54.4
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 53.92
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 53.57
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 53.57
Identifying the molecular mode of action of itraconazole in colorectal cancer 53.31
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 52.13
RNA-seq of shEZH2 cells 52.07
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 51.88
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 51.63
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 51.49
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 51.49
Transcriptome profiling of Normal and Cancerous Prostate Cells 50.88
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 49.91
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 49.91
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 49.13
ARID1A and ARID1B loss in HCT116 cells 48.82
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 47.77
RNA-Seq analysis of breast cancer cells after shikonin treatment 47.58
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 47.57
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 47.3
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 47.3
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 46.76
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 46.76
MARCKS and lnc-MARCKS act as inflammation regulators 46.15
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 45.79
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 44.99
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 44.89
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 44.89
MYCi361 regulates MYC target genes 44.88
A Unique Epigenomic Landscape Defines Human Erythropoiesis 44.62
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 44.62
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 44.61
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 43.95
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 43.21
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 43.01
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 42.94
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 42.26
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 41.73
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 41.1
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 40.93
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 39.31
GATA3-mediated chromatin reprogramming in breast cancer cells 39.16
IL-33 activates tumor stroma to promote intestinal polyposis 39.07
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 38.78
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 38.55
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 38.53
TGF-β promotes genomic instability after loss of RUNX3 37.91
Lipid degradation promotes prostate cancer cell survival 37.64
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 37.47
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 37.24
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 37.24
Effect of BMP inhibition or stimulation of primary human keratinocytes 36.79
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 36.79
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 36.75
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 36.2
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 35.91
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 35.44
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 35.1
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 35.1
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 34.69
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 34.69
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 34.47
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 34.19
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 34.19
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 34.04
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 33.86
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 33.82
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 33.45
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 33.2
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 33.16
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 32.75
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 32.75
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 32.56
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 32.29
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 32.09
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 32.08
RNA-seq of MDA-MB-231 cells with TET1 knockout 32.08
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 32.06
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 31.96
WRN knockout effects upon gene expression in SW48 and OVK18 31.57
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 31.36
Single-nucleotide-resolution mapping of HBV promoters using CAGE 30.44
Transcriptomic and gene ontology profiling of the human corneal cell types 30.38
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 30.37
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 30.1
A549 cells and MSR-A549 cells 30.1
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 29.6
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 29.38
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 29.34
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 29.24
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 29.23
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 29.04
Regulation of highly expressed hCINAP on translatome 28.71
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 28.29
PTHrP overexpression in MCF7 cells 28.17
RNA-seq of human aneuploid cell lines with Trisomy 21 27.96
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 27.78
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 27.23
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 26.42
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 26.28
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 26.23
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 26.06
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 25.49
Effect of BB608 on Gene Expression in HNSCC Cell Line 25.38
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 25.04
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 25.03
Identification of long noncoding RNAs regulated by p53 25.0
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 24.83
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 24.72
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 24.64
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 24.44
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 24.42
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 24.19
RNA-seq of YB5 cells treated with Proscillaridin A 24.1
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 24.07
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 24.07
Gene expression alterations of pancreatic intraepithlial neoplasia 23.94
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 23.81
CSL 23.09
CSL RNA-Seq on HKC and SCC cell lines 23.09
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 23.05
Gene Expression Profiling of SPOP Knocked Down Cell 23.0
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 22.95
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 22.84
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 22.78
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 22.69
ARID1A regulates condensin II distribution and chromosomal partition 22.65
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 22.65
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 22.48
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 22.47
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 22.47
BASP1 modifies the Tamoxifen response 22.17
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 22.11
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 22.08
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 22.08
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 22.06
RNA-seq differential expression studies: more sequence, or more replication? 22.01
A prostate cancer chromatin interaction map 21.78
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 21.77
Differential Gene Expression between MCF10A and MCF7 cells 21.61
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 21.49
mRNA-sequencing of breast cancer subtypes and normal tissue 21.39
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 21.31
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 21.22
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 21.09
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 21.03
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 20.76
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 20.59
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 20.47
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 20.44
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 20.44
snRNAs as regulators of alternative splicing 20.31
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 20.29
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 20.27
Control of prostate tumour growth by the long non-coding RNA GHSROS 20.23
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 20.2
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 19.92
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 19.73
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 19.73
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 19.49
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 19.35
RNA m5C Methylation in breast cancer using MeRIP-Seq 19.2
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 19.1
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 19.05
Nucleoporin-mediated regulation of cell identity genes 19.0
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 18.84
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 18.6
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 18.54
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 18.54
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 18.49
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 18.26
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 18.26
Reassessment of Exosome Composition 18.12
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 17.76
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 17.68
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 17.6
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 17.51
Identification of differentially expressed genes between senescence and senescence bypass cells 17.36
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 17.21
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 17.17
Active translatome profiling with RiboLace in MCF7 cells 17.12
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 16.94
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 16.84
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 16.84
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 16.8
RNA sequencing analysis of selumetinib-resistant CRC cells lines 16.44
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 16.36
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 16.01
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 16.01
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 15.9
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 15.9
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 15.8
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 15.74
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 15.67
Redifferentiation of expanded human islet β cells by inhibition of ARX 15.66
AR-independent prostate cancer is sustained through FGF signaling 15.55
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 15.35
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 15.33
MCF10A H-Ras RNA-Seq 15.25
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 15.03
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 15.03
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 14.91
Genome-wide analysis of Dengue virus 2 infected cells 14.81
Role of COP1 on MAP kinase transcriptional output in melanoma 14.81
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 14.78
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 14.52
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 14.52
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 14.42
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 14.42
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 14.42
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 14.4
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 14.35
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 14.3
The Human Testis Cell Atlas via Single-cell RNA-seq 14.11
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 14.11
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 13.93
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 13.93
RNA-seq of cells with TET1 knockout 13.92
Gene expression analysis of human liver progenitor-like cells in culture 13.92
Expression profiling of etoposide-induced senescent cells 13.89
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 13.8
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 13.73
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 13.73
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 13.68
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 13.63
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 13.63
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 13.6
Hepatitis C virus functionally sequesters miR-122 13.53
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 13.53
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 13.52
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 13.43
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 13.36
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 13.3
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 13.24
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 13.18
Characterization of human ILC2 subsets 13.1
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 13.07
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 13.05
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 13.05
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 13.03
Neonatal and adult human testis defined at the single-cell level 13.0
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 12.68
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 12.64
Transcriptional effect of ETV1 knockdown in melanoma cells 12.64
Gene expression analysis of breast cancer cell-lines 12.62
Gene expression and genome-wide location analysis of breast cancer cell-lines 12.62
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 12.59
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 12.49
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 12.44
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 12.32
Metastasis in triple-negative breast cancer 12.32
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 12.27
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 12.06
Expression profiling of converted and control dermal BJ fibroblasts 12.06
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.88
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 11.88
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 11.88
Selective expression of long non-coding RNAs in a breast cancer cell progression model 11.74
The effect of Abl kinases on non-small cell carcinoma global transcriptome 11.73
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 11.64
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 11.48
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 11.18
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.04
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 10.96
RNA seq comparison between scrambled and shGRP78 cells 10.9
Effect of Hotair overexpression in human breast cancer cell lines 10.8
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 10.8
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 10.69
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 10.68
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 10.42
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.38
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.38
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 10.34
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 10.28
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 10.17
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 10.1
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 9.97
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 9.71
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 9.64
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.63
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 9.47
MRTF activates TEAD-YAP target gene expression 9.37
Gene Expression Profiling of WT and KDM3A Knocked out Cell 9.33
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 9.33
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 9.28
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 9.27
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 9.25
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 9.2
Gene expression profiling of human and murine in vitro muscle differentiation 9.19
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 9.13
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 9.1
RNA-Seq in neutrophils from Antiphospholipid Syndrome 8.97
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 8.96
Gene expression profile in breast cancer cell lines using RNA sequencing 8.82
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 8.8
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 8.74
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 8.7
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.65
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 8.64
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 8.64
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 8.5
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 8.5
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 8.4
8.3
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.11
MCF-7 as a model for functional analysis of breast cancer risk variants 8.05
Fibroblasts in cholesteatoma activate osteoclasts. 8.02
Total RNA sequencing of APC mutant and wt colonic organoids 8.01
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.97
RNA-seq of IL-4 stimulated human keratinocytes 7.96
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 7.95
A single cell reference map for human blood and tissue T cell activation 7.93
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.65
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 7.52
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 7.52
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.52
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 7.45
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 7.4
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 7.4
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 6.89
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 6.85
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 6.78
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 6.72
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 6.68
The transcriptome of Kawasaki Disease arteritis 6.46
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 6.41
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 6.41
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.3
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 6.21
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 6.21
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 6.18
Role of cervicovaginal microbiota in genital inflammation 6.06
Expression patterns in chronic thromboembolic pulmonary hypertension 6.0
Targeted enhancer activation by a subunit of the integrator complex 5.95
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 5.87
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 5.87
Epigenome regulation during epidermal lineage commitment 5.85
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 5.69
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 5.65
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 5.54
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.53
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 5.44
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 5.41
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.4
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 5.38
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.36
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.32
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 5.24
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 5.24
RNAseq analysis of ruxolitinib treated breast cancers 5.23
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.14
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 5.1
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.07
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 4.99
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.97
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.93
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 4.8
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.77
RNA-Seq of Breast and Ovarian Cancer Cell Lines 4.77
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.73
Transcriptome analysis reveals differential splicing events in IPF lung tissue 4.63
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 4.5
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 4.43
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.38
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 4.33
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 4.25
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 4.18
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.17
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.17
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 4.15
An siRNA screen identifies CHD4 as a target for epigenetic therapy 4.08
Leucegene: AML sequencing (part 6) 4.06
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.96
Finding missing proteins from epigenetically manipulated human cells 3.62
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 3.5
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 3.5
Epigenome regulation during epidermal lineage commitment [RNA-seq] 3.42
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.03
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 3.02
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.93
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.89
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.82
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.82
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.78
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.72
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.71
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.67
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.46
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.45
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.44
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.4
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.26
Patient-derived luminal breast cancer xenografts with progestins 2.18
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 2.18
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.01
Leucegene: ALL sequencing 1.98
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.88
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.83
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.78
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.76
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 1.75
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.71
Single-Cell Genotyping of Transcriptomes 1.71
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.66
ML29755 RNA-seq data 1.64
RNA seq_PDX2_SHP099 1.63
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.63
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.56
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.54
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.54
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.54
Specific molecular signatures underlie response to decitabine in CMML 1.53
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.53
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.5
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.39
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.38
A549 cell transcriptome responses to infection with H7N9 influenza virus 1.22
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.19
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.16
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 1.1
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.03
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.02
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.91
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.91
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.91
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.91
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.87
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.6
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 0.52
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 0.47
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.47
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.46
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.39
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.36
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.36
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 0.23
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.18
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.18
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.09
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.08
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.01
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.01
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.01
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation